HYTN INNOVATIONS MMOED overview

VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce the launch of its Good Manufacturing Practice (GMP) Stability Program and the validation of its cannabis vape cartridges for international distribution. This initiative builds upon HYTN’s January 21, 2025, announcement of its strategic partnership with SNDL Inc. to...

VANCOUVER, British Columbia, Feb. 17, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a comprehensive collaboration (the “Collaboration”) with A1 Cannabis Inc. (“A1”), owner of Summit Cannabis Beverages ("Summit"). Through the Collaboration, the Company and A1 seek to enhance operational efficiency...

VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“ HYTN ” or the “Company ”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a collaboration agreement (the Agreement) with SNDL Inc. (NASDAQ: SNDL) (" SNDL "), one of the world’s largest vertically integrated cannabis companies, to jointly develop Good Manufacturing Practices (GMP) compliant...

VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“ HYTN ” or the “Company ”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce that it has received a new set of import permits from the United Kingdom’s Home Office and corresponding export permits from Health Canada. These permits enable the fulfillment of international orders totaling over 400...

VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“ HYTN ” or the “Company ”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce the receipt of an initial purchase order under manufacturing and pricing agreements (the Agreements) with SNDL Inc. (NASDAQ: SNDL) (" SNDL "), one of the world’s largest vertically integrated cannabis companies. This...

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or "the Company"), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce its successful export of cannabis to the United Kingdom’s 4C LABS. This announcement follows the news from November 28, 2024, that the Company received its...

VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce the receipt of initial orders and import permits from the UK's 4C Labs, marking a significant milestone in their partnership. This achievement allows...

VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a company specializing in the pharmaceutical development and production of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has engaged bullVestor Medien GmbH (“bullVestor”) (address: Gutenhofen 4, 4300, St. Valentin, Austria email: kontakt@bullvestor.at ) to provide marketing...